{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["34(1)"],"submitter":["Nazzaro M"],"journal":["Molecular Therapy Oncology"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12936832"],"repository":["biostudies-literature"],"pubmed_title":["Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression"],"pmcid":["PMC12936832"],"pubmed_authors":["Glaspell A","Elemento O","Behbehani G","Cripe T","Nazzaro M","Mardis E","Currier M","Canella A","Bhinder B","Rajappa P","Lee D"],"additional_accession":[]},"is_claimable":false,"name":"Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression","description":null,"dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Feb","modification":"2026-07-16T21:55:20.651Z","creation":"2026-07-10T03:15:12.801Z"},"accession":"S-EPMC12936832","cross_references":{}}